ALAN HUSSEIN: Open Payments
NPI 1306386339 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,492 in 67 payments from 15 companies in 2025. Trend: 2023 $553 · 2024 $1,090 · 2025 $1,492
Food & beverage: $1,492
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $298 |
| Exact Sciences Corporation | 8 | $183 |
| AstraZeneca Pharmaceuticals LP | 8 | $173 |
| ABBVIE INC. | 8 | $155 |
| Lilly USA, LLC | 7 | $126 |
| Axsome Therapeutics, Inc. | 4 | $103 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $103 |
| GlaxoSmithKline, LLC. | 5 | $90 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $83 |
| PFIZER INC. | 4 | $70 |
Products named: Cologuard Collection Kit, JARDIANCE, Ozempic, Auvelity, CAPLYTA, Wegovy, BREZTRI, QULIPTA.
Industry payments across MI — which companies pay providers there.
